Diabetologie und Stoffwechsel, Inhaltsverzeichnis Diabetologie und Stoffwechsel 2013; 8(5): 375-376DOI: 10.1055/s-0033-1362069 Fallbericht © Georg Thieme Verlag KG Stuttgart · New YorkFallbericht – Ikterus durch Diabetes- Therapie Anja Hieronimus , Robert WagnerArtikel empfehlen Abstract Artikel einzeln kaufen Volltext Referenzen Literatur 1 Scheen A. Thiazolidinediones and liver toxicity. 2001 http://orbi.ulg.ac.be/handle/2268/12157 (accessed 21 May2013). 2 Miralles-Linares F, Puerta-Fernandez S, Bernal-Lopez MR, Tinahones FJ, Andrade RJ, Gomez-Huelgas R. Metformin-induced hepatotoxicity. Diabetes Care 2012; 35: e21 3 Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 1996; 30: 359-71 4 Uetrecht J. Immunoallergic drug-induced liver injury in humans. Semin Liver Dis. 2009; Nov 29 (4) 383-92 Epub 2009 Oct 13. 5 Biyyani RS, Battula S, Erhardt CA, Korkor K. Metformin-induced cholangiohepatitis. BMJ Case Rep. 2009; 2009. pii: bcr09. 2008. 0950. Epub 2009 Jul 14. 6 Murano T, Oyama T, Miyashita Y, Shirai K. A case of obstructive jaundice with severe hypercholesterolemia probably due to lipoprotein-Y. J Atheroscler Thromb 2008; 15: 276-80 7 Ooi K, Shiraki K, Sakurai Y, Morishita Y, Nobori T. Clinical significance of abnormal lipoprotein patterns in liver diseases. Int J Mol Med. 2005; Apr; 15: 655-60 8 DeCensi A, Puntoni M, Goodwin P et al. Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis. Cancer Prev Res 2010; 3: 1451-61 9 Emami Riedmaier A, Fisel P, Nies AT, Schaeffeler E, Schwab M. Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects. Trends Pharmacol Sci 2013; 34: 126-35